ClinicalTrials.gg
CompletedNCT04889508Updated Jan 23, 2023

Investigating Differential Effects of Online Mental Training Interventions on Mental Well-being and Social Cohesion

An interventional study of Socio-emotional mental training and Mindfulness-based mental training in Depressive Symptoms, Stress and Empathy, sponsored by Max Planck Social Neuroscience Lab. Completed at 1 site in Germany. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-23.

Sponsored by Max Planck Social Neuroscience Lab · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
285
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 268 studies in Depression with a site in Germany — 40 open to participants now, 45 under way, 4 of them phase 3. Depression · Germany.

Enrollment
59th of 219
285 · median 120
Started
2021
with 13 others
No phase
147 of 268
24 open now
Registered
190th of 268
by date

Among the 268 studies in Depression with a site in Germany, this one is the 59th largest by enrollment of the 219 interventional ones that give a count, is one of 14 that started in 2021, is one of 147 with no phase, and was the 190th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

40 of the 268 studies in Depression with a site in Germany are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 268 studies in Depression with a site in Germany, or all of them as a file.
02

Study summary

The SARS-CoV-2 pandemic, and the associated government-imposed isolationary lockdowns, has led to a mental health crisis on a global scale. Empirical studies have reported a drastic increase in mental health problems, such as depression and anxiety, increased loneliness and feelings of disconnectedness from others, while resilience levels have been negatively affected, indicating an urgent need for intervention. The current study study is embedded in a larger study, the CovSocial study (www.covsocial) which focused in its first phase on evaluating the longitudinal changes in vulnerability, resilience and social cohesion during the SARS-CoV-2 pandemic. The present second phase of this CovSocial study will seek to investigate the efficacy of brief online mindfulness-based and socio-emotional interventions in reducing mental health problems, and enhancing psychological resilience, social competencies and social cohesion.

After providing informed consent, participants will be assigned to one of three groups: 1) socio-emotional training group (with Affect Dyads as core exercise), 2) mindfulness-based mental training group (with attention-based mindfulness practices such as Breathing Meditation as core practice), or 3) Retest Control Group (waitlist control).All groups will first undergo a pre-intervention testing phase (pre-test) wherein they will provide a comprehensive baseline measurement which covers psychometric measures (such as questionnaires and behavioral tasks), and biological parameters (saliva samples). During the 10-week intervention period, participants will undergo weekly assessments and daily Ecological Momentary Assessment pre and post the daily exercise practice, using self-report scales and questionnaires delivered through a webapp or mobile app. At the end of the intervention, participants will again undergo an assessment of psychometric measures and biological parameters, same as at pre-intervention time (post-test). In a second portion, the waitlist control group will undergo the socio-emotional intervention and will be tested at post-test II again.

Results will reveal the effectiveness of brief online interventions in enhancing mental health and social cohesion outcomes. In addition to examining pre-post intervention-related changes, we will also use the data from the phase 1 of the project to evaluate the impact of trait markers of and the longitudinal changes in vulnerability, resilience and social cohesion on the intervention-related changes in markers of vulnerability, resilience and social cohesion. We will also evaluate the predictive impact of genetic markers of vulnerability, resilience and social cohesion (assessed in phase 1) on intervention-related changes in our variables of interest.

The present study will serve as a pilot for future application of scalable, low-cost interventions at a broader level to reduce stress, improve mental health and build resilience in the face of global stressors.

03

Conditions studied

  • Depressive Symptoms
  • Stress
  • Empathy
  • Compassion
  • Prosocial Behavior
  • Anxious Symptoms
  • Loneliness
  • Resilience
  • Genetic Markers
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants will have to meet the following inclusion criteria:

  1. between 18 and 65 years age
  2. resident of Berlin
  3. proficiency in German.

Exclusion criteria

Exclusion Criteria:

Participants would be excluded:

  1. if they do not have access to internet or technical equipment necessary
  2. if they have an educational background in psychology
  3. if they have regular spiritual practice (including yoga practice with meditative component)
  4. if they take medication that influences physiological markers
  5. if they have participated in stress reduction programs previously
  6. if they suffer from a chronic illness or pain, or if they have a history of or current psychiatric diagnosis.
  7. Toronto Alexithymia Scale-20 (TAS-20; exclude if score greater than 60)
  8. Patient Health Questionnaire-9 (PHQ-9; exclude if scores greater than 19)
  9. Generalized Anxiety Disorder-7 (GAD-7; exclude if scores greater than 15)

Moreover, participants endorsing suicidality on the PHQ-9 will be excluded. Lastly, participants will be further screened for personality disorder on the Standardized Assessment of Severity of Personality Disorder questionnaire and for endorsement of clinical levels of psychological disorder on CID-S.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
285 participants (actual)

Study arms

  • Experimental
    Socio-emotional mental training

    The socio-emotional intervention will consist of 10 weeks of daily Affect Dyad practice with a partner.

    Behavioral: Socio-emotional mental training

  • Experimental
    Mindfulness-based mental training

    The intervention will consist of 10 weeks of daily individual Breathing Meditation practice.

    Behavioral: Mindfulness-based mental training

  • Other
    Retest Control Group (Waitlist control)

    The retest control group, which is also a waitlist control group, will first not undergo an intervention, but will be tested prior to and after the 10-week period at Pre- and Post-test wherein other groups undergo the interventions. In a second step, the waitlist control group will then also undergo a 10-week period of socio-emotional intervention. During the first 10-week intervention period, this group will only be tested serving as a re-test control group. After Post-test, however, they will be given the chance to also enroll in a 10-week socio-emotional mental training with the exact same protocol as the socio-emotional intervention experimental group above. Both the experimental intervention arm groups will be given the possibility to continue their daily assigned practices (respective socio-emotional and mindfulness-based training exercises) after post-test for the duration of the 10-weeks during which the waitlist control group undergoes the socio-emotional intervention.

    Behavioral: Socio-emotional mental training

Interventions

  • BehavioralSocio-emotional mental training

    Core practice: Affect Dyad. In the Affect Dyad (AD), participants perform a 12-minute partner-based exercise which involves contemplating over one difficult situation and one situation which incurred gratitude in the past 24 hours. Both partners take turns speaking about the two situations while the other partner listens in a non-judgmental manner. While the participants elaborate on the situations, they are asked to focus on the bodily experience of the emotions generated during the situation. The goal of the exercise is to enhance coping with difficult emotions, empathic listening, social sharing, acceptance, and gratitude.

  • BehavioralMindfulness-based mental training

    Core practice: Breathing Meditation. In this intervention, participants will practice 12-minute basic attention-based mindfulness meditation such as the Breathing Meditation (BM). BM is a 12-minute individual exercise that requires participants to focus their attention on the sensations of breathing. Participants have to sustain their attention to breath for long stretches of time, and have to return their attention to their breath when their mind wanders. The key focus is on training attention and interoceptive body awareness. Other practices participants will be taught is mindfulness on sounds (here the object of attention is not the breath but sounds in the environment).

06

What researchers measure

Primary outcomes

  1. Change from baseline Beck Depression Inventory (BDI)-II scores at 10 weeks

    A scale measuring depression symptoms. Higher scores indicate more depression symptoms.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  2. Change from baseline State Trait Anxiety Inventory (STAI) scores at 10 weeks

    A scale measuring state and trait anxiety symptoms. Higher scores indicate more anxiety symptoms.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  3. Change from baseline Connor Davidson Resilience Scale (CDRISC) score at 10 weeks

    A scale measuring psychological resilience. Higher scores indicate more resilience.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  4. Change from baseline UCLA Loneliness Scale at 10 weeks

    A scale measuring loneliness. Higher scores indicate more subjective loneliness.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  5. Change from baseline State Self Compassion Scale (S-SCS) scores at 10 weeks

    A scale measuring compassion towards self. Higher scores indicate more self-compassion.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  6. Change from baseline Perceived Stress Scale (PSS)-10 scores at 10 weeks

    A scale measuring perceived stress. Higher scores indicate more perceived stress.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  7. Change from baseline Interpersonal Reactivity Index (IRI) scores at 10 weeks

    A scale measuring four aspects of empathy. Higher scores indicate more empathy.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  8. Change from baseline Cortisol Awakening Response at 10 weeks

    Cortisol Awakening response.

    Time frame: Assessed at pre-intervention over a period 2 days (Baseline), and then after 10-week intervention period at post-intervention timepoint again for 4 days

  9. Change from baseline Subjective Stress levels at 10 weeks

    Assessment of quality of sleep, stressor appraisal, coping with stressor, affective state, valence and temporal orientation of thoughts, perceived emotional control, and interoceptive awareness. Using Ecological Momentary Assessment(EMA).

    Time frame: Assessed at pre-intervention over a period 8 days (Baseline), and then after 10-week intervention period at post-intervention timepoint again for 8 days

  10. Change from baseline Brief Resilience Scale (BRS) scores at 10 weeks

    A scale measuring adaptive resilience. Higher scores indicate more resilience.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  11. Change from baseline Difficulties in Emotion Regulation Scale (DERS)-18 scores at 10 weeks

    A scale measuring difficulties in use of emotion regulation strategies. Higher scores indicate more difficulties in emotion regulation.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  12. Change from baseline Cognitive Emotion Regulation Questionnaire (CERQ)-18 scores at 10 weeks

    A scale measuring use of emotion regulation strategies. Higher scores on a strategy sub scale indicate more use of the emotion regulation strategy.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  13. Change from baseline Fear of Compassion Scale (FoC) scores at 10 weeks

    A scale measuring fear of compassion towards self. Higher scores indicate more fear of compassion.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  14. Change from baseline Social Value Orientations (SVO) scores at 10 weeks

    A task measuring social value orientations and prosocial behavior. Number of choices will be used as the dependent variable.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  15. Change from baseline Zurich Prosocial Game scores at 10 weeks

    A behavioral task assessing levels of prosocial behavior towards others. Number of keys invested in will serve as the dependent variable.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  16. Change from baseline EmpaToM scores at 10 weeks

    A behavioral task assessing empathy and theory of mind. Valence and compassion ratings will serve as the dependent variables.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  17. Change from baseline Social Discounting Task scores at 10 weeks

    A behavioral task assessing prosocial behavior and altruism. The degree of discounting will serve as the dependent variable.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  18. Change from baseline Multidimensional Assessment of Interoceptive Awareness (MAIA) scores at 10 weeks

    A scale measuring interoception. Higher scores indicate more interoceptive awareness.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  19. Change from baseline Sussex-Oxford Compassion Scale (SOC) scores at 10 weeks

    A scale measuring compassion. Higher scores indicate more compassion.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  20. Change from baseline Toronto Alexithymia Scale scores at 10 weeks

    A scale measuring Alexithymia. Higher scores indicate more alexithymia.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  21. Change from baseline Trier Social Stress Test (TSST) scores at 10 weeks

    A task assessing cortisol response to social stress. Subjective stress and cortisol levels will serve as the dependent variables.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

Secondary outcomes

  1. Change in baseline Dot Probe Task (mediating variable) scores at 10 weeks

    A behavioral task assessing attention bias toward positive and negative stimuli. Negative and positive attention bias indices will serve as dependent variables.

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  2. Change in baseline Scrambled Sentences Task (mediating variable) scores at 10 weeks

    A behavioral task assessing interpretation bias toward positive and negative stimuli. Negative and positive interpretation bias indices will serve as dependent variables

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  3. CERQ - Acceptance, Rumination, and Reappraisal (explanatory mechanism)

    A scale measuring use of only three emotion regulation strategies

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  4. FoC - Fear of Expressing Compassion for Others (explanatory mechanism)

    A scale measuring how much people fear expressing compassion towards others

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  5. FoC - Fear of Expressing Kindness and Compassion Towards Oneself (explanatory mechanism)

    A scale measuring how much people fear expressing compassion towards self

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  6. S-SCS - Self-kindness (explanatory mechanism)

    A scale measuring levels of kindness shown towards self

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  7. S-SCS - Common Humanity (explanatory mechanism)

    A scale measuring feelings of shared humanity

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  8. Five Facet Mindfulness Questionnaire (FFMQ; explanatory mechanism)

    A scale measuring mindfulness on 5 different sub scales. 1 item with the highest factor loading on each of the 5 subscales.

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  9. Stress Assessment Questions

    A scale assessing the occurrence and nature of a stressor

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups in the context of a stressor

  10. Inclusion of Other in the Self Scale

    A scale assessing sense of belonging and social connectedness

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups in the context of a stressor

  11. Frequency and quality of social interaction, and empathic listening

    A scale assessing quality of social interactions and listening

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups in the context of a stressor

  12. Penn State Worry Questionnaire (PSWQ)-3 (explanatory mechanism)

    A scale measuring levels of worry

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  13. IRI - Personal Distress (explanatory mechanism)

    A scale measuring levels of personal distress felt when showing empathic concern

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  14. MAIA - Self-Regulation and Body Listening (explanatory mechanisms)

    A scale measuring levels of interoceptive awareness

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  15. Cognitive Control and Flexibility Questionnaire (CCFQ) - Cognitive Control over Emotions (explanatory mechanism)

    A scale measuring cognitive control exhibited over emotional material

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  16. Acceptance and Action Questionnaire (AAQ)-II (explanatory mechanism)

    A scale measuring psychological flexibility

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  17. DERS (explanatory mechanism)

    1 item each from the following subscales: Nonacceptance of emotional responses, Difficulty engaging in Goal-directed behavior, Lack of emotional awareness, Limited access to emotion regulation strategies, Lack of emotional clarity.

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  18. Brief-COPE (explanatory mechanism)

    A scale measuring the frequency of 2 coping strategies used - emotional support and instrumental support

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  19. PSS-4

    A scale measuring perceived stress

    Time frame: Assessed weekly during the course of 10 weeks of intervention only in intervention groups

  20. Affect Grid (explanatory mechanism)

    Assessment of emotional state (valence) and arousal

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  21. Cube of Thoughts (explanatory mechanism)

    A scale measuring the temporality and valence of thoughts

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  22. Interoception (explanatory mechanism)

    Assessment of how much bodily sensations are felt

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  23. Engagement (explanatory mechanism)

    Assessment of how engaged participants felt in the exercise

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, only once after the daily exercise

  24. Social connectedness - Inclusion of Other in Self Scale (explanatory mechanism)

    Assessment of how connected participant felt to the dyad partner

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the AD intervention group, prior to and after the daily exercise

  25. Personal Detail Shared (explanatory mechanism)

    Assessment of the level of personal details shared by the participant during exercise

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the AD intervention group, only after the daily exercise

  26. Loneliness (explanatory mechanism)

    Assessment of the level of loneliness by the participant before and after exercise

    Time frame: Assessed for 10 weeks during intervention period, 3 times a week, only in the intervention groups, prior to and after the daily exercise

  27. Change from baseline Inflammation Marker levels at 10 weeks

    Assessment of C-reactive protein (CRP) levels through saliva sample

    Time frame: Assessed at pre-test (Baseline) and then after 10-week intervention period at post-intervention timepoints

  28. Change from baseline Polyepigenetic risk scores at 10 weeks

    Assessment of epigenetic markers through saliva

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints only in intervention groups

  29. Belonging to COVID-19 biological risk group

    Yes or No

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  30. Belonging to COVID-19 professional risk group

    Yes or No

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  31. Positive test result for COVID-19

    Yes or No

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  32. Presence of COVID-19 symptoms

    Yes or No

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  33. Hospitalization due to COVID-19

    Yes or No

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  34. Duration of hospitalization due to COVID-19 (in weeks)

    Number of weeks

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  35. History of or current presence of long-covid symptoms

    Yes or No

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  36. Status of COVID-19 vaccination

    received none, first or both doses

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  37. Perception of benefits of COVID-19 vaccination

    in case of one or two doses received willingness to receive COVID-19 vaccination (in case of no dose received), and impact of COVID-19 related restrictions and limitations

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

  38. Willing to receive COVID-19 vaccination

    Yes or No. Only in case of no dose received

    Time frame: Assessed at pre-intervention (Baseline) and then after 10-week intervention period at post-intervention timepoints

Other outcomes

  1. TAS-20 (pre-screening)

    A scale assessing alexithymia

    Time frame: Assessed prior to the intervention, only once, to pre-screen out from the study individuals who have high levels of alexithymia

  2. PHQ-9 (pre-screening)

    A scale assessing depression

    Time frame: Assessed prior to the intervention, only once, to pre-screen out from the study individuals who have clinical levels of depressive symptoms

  3. GAD-7 (pre-screening)

    A scale assessing generalized anxiety

    Time frame: Assessed prior to the intervention, only once, to pre-screen out from the study individuals who have clinical levels of anxious symptoms

  4. Standardized Assessment of Personality - Abbreviated Scale (pre-screening)

    A self-report scale used to screen personality disorders

    Time frame: Assessed prior to the intervention, only once, to evaluate presence of personality disorders

  5. Composite International Diagnostic Screener CID-S (pre-screening)

    A self-report scale used to screen mental health

    Time frame: Assessed prior to the intervention, only once, to pre-screen out from the study individuals endorsing clinical levels of psychological disorders

07

Study locations

1 site
  • Social Neuroscience Lab
    Berlin, Germany
08

References and documents

Publications

  • Godara M, Silveira S, Matthaus H, Heim C, Voelkle M, Hecht M, Binder EB, Singer T. Investigating differential effects of socio-emotional and mindfulness-based online interventions on mental health, resilience and social capacities during the COVID-19 pandemic: The study protocol. PLoS One. 2021 Nov 4;16(11):e0256323. doi: 10.1371/journal.pone.0256323. eCollection 2021. PubMed 34735441 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2021 to primary completion in Mar 2022, 10 months.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 10 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2021
First posted
May 17, 2021
StartActual
May 7, 2021
Primary completionActual
Mar 31, 2022
CompletionActual
Mar 31, 2022
Last update
Jan 23, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04889508
Lead sponsor
Max Planck Social Neuroscience Lab
Collaborators
Charite University, Berlin, Germany, Humboldt-Universität zu Berlin, Max-Planck-Institute of Psychiatry
Responsible party
Sponsor
First posted
May 17, 2021
Start date
May 7, 2021
Primary completion
Mar 31, 2022
Completion
Mar 31, 2022
Last update
Jan 23, 2023

Study contacts

Tania Singer, PhD
principal investigator · Social Neuroscience Lab, Max Planck Society

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion